<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:ifp="http://www.ifactory.com/press" ifp-element-xpath="/*[local-name() = 'urlset' and namespace-uri() = 'http://www.sitemaps.org/schemas/sitemap/0.9']"><ifp:contentType>ARTICLE</ifp:contentType><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1047.xml</sm:loc><ifp:title>Hillary and Donald, Our Patients Are Watching</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1047.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Hillary and Donald, Our Patients Are Watching</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-pxvii.xml</sm:loc><ifp:title>NCCN News</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-pxvii.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN News</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-pxxiv.xml</sm:loc><ifp:title>Oncology Research Program</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-pxxiv.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Oncology Research Program</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1052.xml</sm:loc><ifp:title>Allogeneic Hematopoietic Cell Transplantation for AML—A Missed Opportunity!</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1052.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Allogeneic Hematopoietic Cell Transplantation for AML—A Missed Opportunity!</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1111.xml</sm:loc><ifp:title>The Population Benefit of Radiotherapy for Malignant Brain Tumors: Local Control and Survival Estimates for Guideline-Based Use</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1111.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>The Population Benefit of Radiotherapy for Malignant Brain Tumors: Local Control and Survival Estimates for Guideline-Based Use</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1121.xml</sm:loc><ifp:title>Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1121.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1098.xml</sm:loc><ifp:title>Current Status of Distress Screening in Designated Cancer Hospitals: A Cross-Sectional Nationwide Survey in Japan</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1098.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Current Status of Distress Screening in Designated Cancer Hospitals: A Cross-Sectional Nationwide Survey in Japan</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1067.xml</sm:loc><ifp:title>NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1067.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1081.xml</sm:loc><ifp:title>Predictors of Antiestrogen Recommendation in Women With Estrogen Receptor–Positive Ductal Carcinoma In Situ</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1081.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Predictors of Antiestrogen Recommendation in Women With Estrogen Receptor–Positive Ductal Carcinoma In Situ</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1054.xml</sm:loc><ifp:title>Characterization of Prostate Cancer in a Functional Eunuch</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1054.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Characterization of Prostate Cancer in a Functional Eunuch</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1185.xml</sm:loc><ifp:title>Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1185.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1175.xml</sm:loc><ifp:title>Principles of Treatment for Borderline, Micropapillary Serous, and Low-Grade Ovarian Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1175.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Principles of Treatment for Borderline, Micropapillary Serous, and Low-Grade Ovarian Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1134.xml</sm:loc><ifp:title>Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1134.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1165.xml</sm:loc><ifp:title>Next-Generation Sequencing: Role in Gynecologic Cancers</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/14/9/article-p1165.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Next-Generation Sequencing: Role in Gynecologic Cancers</ifp:title></sm:url></urlset>
